Suppr超能文献

复发性 WHO 分级 I 级脑膜瘤的组织学转化。

Histological transformation in recurrent WHO grade I meningiomas.

机构信息

Department of Neurosurgery, Geneva University Hospitals, Rue Gabrielle Perret Gentil 4, 1205, Geneva, Switzerland.

Department of Neurosurgery, Angers University Hospitals, Rue Larrey 4, 49100, Angers, France.

出版信息

Sci Rep. 2020 Jul 8;10(1):11220. doi: 10.1038/s41598-020-68177-x.

Abstract

Atypical or malignant transformation (AT/MT) has been described in WHO grade I meningiomas. Our aim was to identify predictive factors of AT/MT at recurrence. A total of N = 15 WHO grade increases were observed in N = 13 patients (0.96% of the study population, risk of transformation of 0.12% per patient-year follow-up). Patients with and without progression at recurrence were similar regarding age, gender distribution, skull-base location, bone infiltration, and Simpson grades. Recurrence-free survival was lower in patients with transformation (5 ± 4.06 years versus 7.3 ± 5.4 years; p = 0.03). Among patient age, gender, skull base location, extent of resection or post-operative RT, no predictor of AT/MT was identified, despite a follow-up of 10,524 patient-years. The annual risk of transformation of WHO grade I meningiomas was 0.12% per patient-year follow-up. Despite the important number of patients included and their extended follow-up, we did not identify any risk factor for transformation. A total of 1,352 patients with surgically managed WHO grade I meningioma from a mixed retro-and prospective database with mean follow-up of 9.2 years ± 5.7 years (0.3-20.9 years) were reviewed. Recurring tumors at the site of initial surgery were considered as recurrence.

摘要

非典型或恶性转化(AT/MT)已在 WHO 分级 I 脑膜瘤中描述。我们的目的是确定复发时 AT/MT 的预测因素。在 N = 13 名患者(研究人群的 0.96%,每位患者每年随访的转化风险为 0.12%)中观察到总共 N = 15 次 WHO 分级增加。复发时进展和无进展的患者在年龄、性别分布、颅底位置、骨浸润和 Simpson 分级方面相似。转化患者的无复发生存率较低(5 ± 4.06 年与 7.3 ± 5.4 年;p = 0.03)。尽管随访时间长达 10,524 患者年,但在患者年龄、性别、颅底位置、切除程度或术后放疗方面,没有发现 AT/MT 的预测因素。WHO 分级 I 脑膜瘤的年转化风险为每位患者每年随访 0.12%。尽管纳入了大量患者并进行了延长随访,但我们未发现任何转化的危险因素。我们回顾了来自回顾性和前瞻性混合数据库的 1,352 名接受手术治疗的 WHO 分级 I 脑膜瘤患者,平均随访 9.2 ± 5.7 年(0.3-20.9 年)。将初始手术部位的复发性肿瘤视为复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fee/7343790/47ddc439185b/41598_2020_68177_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验